2BB score and signals
Cogent Biosciences, Inc.’s current 2BB score is 22 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 30 | Low |
| Momentum | 28 | Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 39 | Low |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 2014 |
| Employees | 258 |
| 52-week range | $11.60 – $43.73 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-15 | — | -0.5703 | — | $11.43M |
| 2026-11-02 | — | -0.5927 | — | $0.00 |
| 2026-08-11 | — | -0.5807 | — | $0.00 |
| 2026-05-05 | -0.6 | -0.5516 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish